论文部分内容阅读
目的:探讨针对小儿肺炎患者采用小儿肺热咳喘口服液进行治疗后的临床效果表现。方法:选取我院2009年08月-2012年08月小儿肺炎患者180例,利用随机数表法对患儿进行平均分组,设为A组与B组。针对B组患儿采用常规方法进行治疗,针对A组患儿在此基础上配合采用小儿肺炎咳喘口服液进行治疗,对两组患儿进行治疗的疗程均为一周,最后对比两组患儿的治疗疗效以及患儿病情好转的情况。结果:比较A组患儿与B组患儿诸多的情况发现,在患儿退热的时间以及咳喘好转的时间等诸多情况均为A组优于B组(P<0.05)。在治疗的有效率方面,A组也高于B组显著(P<0.05)。结论:针对小儿肺炎患者采用小儿肺热咳喘口服液进行治疗后,能够充分发挥出抗炎以及补液等多种作用,并且效果较为明显,具有重要临床意义。
Objective: To investigate the clinical effect of treatment of pediatric pneumonia with pediatric Hyperactivity Kechuan oral solution. Methods: 180 cases of children with pneumonia were selected from August 2009 to August 2012 in our hospital. The children were divided into groups A and B by random number table. For children in group B using conventional methods of treatment for children in group A on this basis with the treatment of children’s pneumonia Kechu Oral Liquid treatment for both groups of children were treated for one week, and finally compared two groups of children Therapeutic efficacy and improvement in children’s condition. Results: Compared with children in group A and group B, we found that group A was superior to group B (P <0.05) in the time of fever relief and the time of cough and asthma improvement in many cases. In the treatment efficiency, A group also higher than the B group (P <0.05). Conclusion: Pediatric pneumonia patients treated with Hyperactivity Kerechs oral solution can exert a variety of effects such as anti-inflammatory and rehydration, and the effect is more obvious, which has important clinical significance.